
Cold Pain Therapy Market Trends, Demand, Share, Growth, Forecast and Future Outlook 3034
Cold Pain Therapy Market Growth, Size, Trends Analysis - By Product, By Application, By Distribution Channel - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
Published: Feb-2025 | Report ID: HLCA2558 | Pages: 1 - 243 | Formats*: |
Category : Healthcare |


- In June 2024, Moov a well-known pain relief company introduced Moov Cool, a novel medication that takes its cues from cold therapy. This product uses the strength of menthol to target joint and muscle pain, including sprains, strains, and injuries, as well as muscle soreness that is frequently associated with an active lifestyle.
- In February 2024, Zynex Inc. A major medical technology company has launched two novel therapy solutions: the Zynex Pro Hybrid LSO and the Zynex DynaComp Cold Compression. Zynex DynaComp Cold Compression offers on-the-go recovery acceleration by smoothly combining compression and cold treatment.
- In October 2023, Hyloris Pharmaceuticals a Belgian company, said that its innovative tablet drug for post-operative pain had been approved by U.S. health regulators. By early next year, the business hopes to introduce the non-opioid treatment in the US. The injectable drug, known by the brand name Maxigesic IV, was approved for use in hospitals after surgery or when patients are unable to take oral medication.
- In March 2023, HealthMe and Breg Inc. revealed a collaboration to introduce a direct-pay eCommerce solution that will improve patient access to orthopaedic cold therapy products by implementing a simplified, automated payment system.
Report Metric | Details |
Market size available for years | 2021-2034 |
Base year considered | 2024 |
Forecast period | 2025-2034 |
Segments covered | By Product, By Application, By Distribution Channel. |
Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa. |
Companies Covered | Beiersdorf, Breg Inc., DJO Global, Johnson & Johnson Services Inc., Medline Industries LP., Ossur, Performance Health, ROHTO Pharmaceutical Co. Ltd., Romsons Group of Industries, Unexo Life Sciences Pvt. Ltd. and others. |
- Global Cold Pain Therapy Market Size (FY’2021-FY’2034)
- Overview of Global Cold Pain Therapy Market
- Segmentation of Global Cold Pain Therapy Market By Product (OTC Products and Prescription Products)
- Segmentation of Global Cold Pain Therapy Market By Application (Orthopedic Conditions, Post-operative Therapy, Sports Medicine and Post-trauma Therapy)
- Segmentation of Global Cold Pain Therapy Market By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and E-commerce)
- Statistical Snap of Global Cold Pain Therapy Market
- Expansion Analysis of Global Cold Pain Therapy Market
- Problems and Obstacles in Global Cold Pain Therapy Market
- Competitive Landscape in the Global Cold Pain Therapy Market
- Details on Current Investment in Global Cold Pain Therapy Market
- Competitive Analysis of Global Cold Pain Therapy Market
- Prominent Players in the Global Cold Pain Therapy Market
- SWOT Analysis of Global Cold Pain Therapy Market
- Global Cold Pain Therapy Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1.1. Scope of the report1.2. Market segment analysis
2.1. Research data source
2.1.1. Secondary Data2.1.2. Primary Data2.1.3. SPERs internal database2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers4.1.2. Restraints4.1.3. Opportunities4.1.4. Challenges
5.1. SWOT Analysis
5.1.1. Strengths5.1.2. Weaknesses5.1.3. Opportunities5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape5.2.2. Economic Landscape5.2.3. Social Landscape5.2.4. Technological Landscape5.2.5. Environmental Landscape5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers5.3.2. Bargaining power of buyers5.3.3. Threat of Substitute5.3.4. Threat of new entrant5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6.1. Global Cold Pain Therapy Market Manufacturing Base Distribution, Sales Area, Interface Type6.2. Mergers & Acquisitions, Partnerships, Interface Launch, and Collaboration in Global Cold Pain Therapy Market
7.1. OTC Products
7.1.1. Gels, Ointments & Creams7.1.2. Sprays & Foams7.1.3. Patches7.1.4. Roll-ons7.1.5. Cold Packs7.1.6. Others
7.2. Prescription Products
7.2.1. Motorized Devices7.2.2. Non-motorized Devices
8.1. Orthopedic Conditions8.2. Post-operative Therapy8.3. Sports Medicine8.4. Post-trauma Therapy
9.1. Hospital Pharmacies9.2. Retail Pharmacies9.3. E-commerce
10.1. Global Cold Pain Therapy Market Size and Market Share
11.1. Asia-Pacific
11.1.1. Australia11.1.2. China11.1.3. India11.1.4. Japan11.1.5. South Korea11.1.6. Rest of Asia-Pacific
11.2. Europe
11.2.1. France11.2.2. Germany11.2.3. Italy11.2.4. Spain11.2.5. United Kingdom11.2.6. Rest of Europe
11.3. Middle East and Africa
11.3.1. Kingdom of Saudi Arabia11.3.2. United Arab Emirates11.3.3. Qatar11.3.4. South Africa11.3.5. Egypt11.3.6. Morocco11.3.7. Nigeria11.3.8. Rest of Middle-East and Africa
11.4. North America
11.4.1. Canada11.4.2. Mexico11.4.3. United States
11.5. Latin America
11.5.1. Argentina11.5.2. Brazil11.5.3. Rest of Latin America
12.1. Beiersdorf
12.1.1. Company details12.1.2. Financial outlook12.1.3. Interface summary12.1.4. Recent developments
12.2. Breg Inc.
12.2.1. Company details12.2.2. Financial outlook12.2.3. Interface summary12.2.4. Recent developments
12.3. DJO Global
12.3.1. Company details12.3.2. Financial outlook12.3.3. Interface summary12.3.4. Recent developments
12.4. Johnson & Johnson Services Inc.
12.4.1. Company details12.4.2. Financial outlook12.4.3. Interface summary12.4.4. Recent developments
12.5. Medline Industries LP
12.5.1. Company details12.5.2. Financial outlook12.5.3. Interface summary12.5.4. Recent developments
12.6. Ossur
12.6.1. Company details12.6.2. Financial outlook12.6.3. Interface summary12.6.4. Recent developments
12.7. Performance Health
12.7.1. Company details12.7.2. Financial outlook12.7.3. Interface summary12.7.4. Recent developments
12.8. ROHTO Pharmaceuticals Co. Ltd.
12.8.1. Company details12.8.2. Financial outlook12.8.3. Interface summary12.8.4. Recent developments
12.9. Romsons Group of Industries
12.9.1. Company details12.9.2. Financial outlook12.9.3. Interface summary12.9.4. Recent developments
12.10. Unexo Life Sciences Pvt. Ltd.
12.10.1. Company details12.10.2. Financial outlook12.10.3. Interface summary12.10.4. Recent developments
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment






Related Reports
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.